Use of a plasma test for verifying epidermal growth factor receptor gene (EGFR) mutations in fluid samples from non-small cell lung cancer patients()

Because epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are effective in the treatment of non-small cell lung cancer (NSCLC) patients with EGFR mutations, it is critical to obtain accurate EGFR mutation test results. For NSCLC patients, EGFR mutation testing is performed usin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogura, Wataru, Ohtsuka, Kouki, Fujiwara, Masachika, Tanaka, Ryota, Sekiguchi, Kumiko, Ohnishi, Hiroaki, Watanabe, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996008/
https://www.ncbi.nlm.nih.gov/pubmed/32025485
http://dx.doi.org/10.1016/j.rmcr.2020.101007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996008/
https://www.ncbi.nlm.nih.gov/pubmed/32025485
http://dx.doi.org/10.1016/j.rmcr.2020.101007

Ejemplares similares